Becton Dickinson lands at Dulles the week of a major FDA advisory panel

Becton Dickinson flew from Manassas Regional Airport to Washington Dulles International Airport on June 4, a short hop of roughly 17 miles that took just under two minutes in the air — more of a repositioning than a journey, but one that lands the company’s Falcon 7X, N294X, at a hub for federal regulators. The flight arrived at 12:31 UTC, according to flight data.

The same week, the U.S. Food and Drug Administration’s Microbiology Devices Panel is scheduled to meet on June 5–6 to discuss new sepsis diagnostic technologies, per the FDA’s public calendar. Becton Dickinson, a leading maker of blood-culture systems and rapid diagnostic platforms, has a direct interest in the panel’s recommendations, which could shape clearance pathways for next-generation sepsis tests. The company’s diagnostics segment generated $4.8 billion in revenue last fiscal year, and sepsis detection remains a high-stakes growth area.

The brief hop from Manassas to Dulles follows a pattern of Washington-area visits: Becton Dickinson’s home base is Morristown, New Jersey, but the company’s regulatory and government-affairs teams frequently operate from the D.C. corridor. Earlier this week, the aircraft flew from Chicago to New Jersey, suggesting a multiday business swing that ended with a face-to-face at the FDA’s suburban Maryland campus.